MetaCap

MiniMed Group Financial Statements

NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD

19.71-0.09 (-0.45%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

MiniMed Group revenue and earnings

In fiscal 2026, MiniMed Group generated $3.10 billion in revenue, up 14.3% from fiscal 2025, its 2nd consecutive year of revenue growth. MiniMed Group reported a net loss of $333.0 million, compared with a loss of $213.0 million a year earlier. Gross margin was 54.2% (down from 56.3%) and operating margin -6.1%.

Diluted earnings per share came in at -$1.30. Over the last 2 fiscal years, MMED's revenue has grown at a 12.1% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

MiniMed Group income statement (annual)

MiniMed Group annual income statement
Fiscal year (USD)FY 20262026-04-24FY 20252025-04-25FY 20242024-04-26
Revenue3.10B2.71B2.47B
Revenue growth (YoY)+14.25%+9.96%—
Cost of Revenue1.42B1.19B1.03B
Gross Profit1.68B1.53B1.44B
Operating Expenses1.87B1.67B1.50B
Research & Development448.00M436.00M437.00M
Selling, General & Admin1.18B1.08B1.06B
Operating Income-190.00M-146.00M-69.00M
Other Income (Expense)1.00M-1.00M-1.00M
Pretax Income-189.00M-147.00M-70.00M
Income Tax128.00M52.00M38.00M
Net Income-333.00M-213.00M-112.00M
Net Income growth (YoY)———
EPS (Basic)-1.30-0.84-0.44
EPS (Diluted)-1.30-0.84-0.44
Shares Outstanding (Basic)256.60M252.80M252.80M
Shares Outstanding (Diluted)256.60M252.80M252.80M
EBITDA-34.00M-3.00M60.00M
Gross Margin54.16%56.28%58.16%
Operating Margin-6.13%-5.38%-2.79%
Net Margin-10.74%-7.85%-4.54%

This table shows 3 annual periods of MiniMed Group's income statement, from FY 2026 back to FY 2024, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MMED's reporting calendar. What is a income statement?

More financial data